Cambridge Cognition (LON:COG) Trading Up 6.3% – Should You Buy?

Cambridge Cognition Holdings Plc (LON:COG) shares were up 6.3% on Friday . The stock traded as high as GBX 37.24 ($0.47) and last traded at GBX 36.15 ($0.45). Approximately 223,769 shares changed hands during trading, an increase of 268% from the average daily volume of 60,742 shares. The stock had previously closed at GBX 34 ($0.43).

Cambridge Cognition Stock Up 6.3 %

The stock has a market cap of £15.16 million, a P/E ratio of -903.75 and a beta of 0.72. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96. The stock’s fifty day simple moving average is GBX 29.11 and its 200-day simple moving average is GBX 36.54.

Insiders Place Their Bets

In related news, insider Stuart Gall purchased 31,250 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was bought at an average price of GBX 32 ($0.40) per share, for a total transaction of £10,000 ($12,583.36). Also, insider Nick (Philip) Rodgers acquired 31,292 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The stock was bought at an average cost of GBX 32 ($0.40) per share, for a total transaction of £10,013.44 ($12,600.28). Insiders own 29.89% of the company’s stock.

Cambridge Cognition Company Profile

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.